Pneumolabs initially focused on the area of respiratory diseases, and as such, we now have a bank of relevant models which we are continuously updating, and a wealth of expertise in this field. As we have grown, and continue to grow and evolve to meet the ever changing needs of our client base, and the scientific environment as a whole, we have broadened this to encompass other inflammatory diseases.
Inflammatory diseases are increasing in prevalence around the globe and affect millions of people annually leading to pain, disability, disfigurement and death. These diseases put a huge burden on individuals and society as the unmet medical need is substantial, with patients often remaining symptomatic for many years despite using the best available therapies.
Pneumolabs provides high quality contract research services to progress compounds from hit identification through to lead optimization.